This first edition report At-Home Testing: COVID-19 Trends and Future Potential provides an overview of trends and developments in the home testing industry for the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present – March 31, 2021.
For the purpose of this report, Kalorama Information concludes that the accepted definition of a home or self-test is one whereby the individual takes the sample, performs the test and then interprets the test result either alone or with the aid of an online consultation service. As of the time of publication in Spring 2021, the major market for COVID-19 self-tests is the United States, therefore the discussion presented in the report focuses on that geography.
Many non-instrumented point-of-care (POC) COVID-19 tests use immunoassays and molecular technologies. They have not been officially designated as home tests but do have the potential to migrate to home-based tests as is deemed necessary by public health agencies. These COVID-19 point-of-care molecular tests are therefore included in this Kalorama Information report.
The report discusses COVID-19 tests and technologies that are currently available and those that are expected to take their place. The report covers trends and issues concerning:
- government support for COVID-19 home tests
- COVID-19 home test sample types
- COVID-19 home test modalities
- OTC and DTC trends in COVID-19 testing
In addition to the various aforementioned trends, tests, and technologies covered in the report, At-Home Testing: COVID-19 Trends and Future Potential profiles several companies active in this market, including:
- Abbott Laboratories
- Becton Dickinson & Company (BD)
- bioMérieux / BioFire Diagnostics
- Cepheid, A Danaher Company
- Fluidigm Corporation
- GenMark Diagnostics, Inc., A Roche Diagnostics Company
- LetsGetChecked/PrivaPath Diagnostics Limited
- Lucira Health
- Mesa Biotech
- OraSure Technologies, Inc.
- QIAGEN N.V.
- Quidel Corporation
- Roche Diagnostics
- Sherlock Biosciences
- Siemens Healthineers